Chemistry:2C-T-31

From HandWiki

2C-T-31, also known as 2,5-dimethoxy-4-(4-trifluoromethylbenzylthio)phenethylamine, is a serotonin receptor modulator of the phenethylamine and 2C families.[1][2][3][4] Its properties and effects in humans do not appear to be known.[1] The drug shows affinity for the serotonin 5-HT2A receptor (Ki = 3.8–28 nM) and much lower affinity for the serotonin 5-HT1A and 5-HT2C receptors (Ki = 1,063 nM and 157 nM, respectively).[4][1] It is a very weak partial agonist or antagonist of the serotonin 5-HT2A receptor (EC50 (Emax) = 53 nM (2.8%)) and a moderate-efficacy but very-low-potency partial agonist of the serotonin 5-HT2B receptor (EC50 (Emax) = 3,309 nM (44%)).[4][2] It also shows weak affinity for a number of other targets.[4] The chemical synthesis of 2C-T-31 has been described.[3] 2C-T-31 was first described in the scientific literature by Daniel Trachsel in 2003.[3][1][4]

See also

References

  1. 1.0 1.1 1.2 1.3 (in de) Phenethylamine: von der Struktur zur Funktion. Nachtschatten-Science (1 ed.). Solothurn: Nachtschatten-Verlag. 2013. ISBN 978-3-03788-700-4. OCLC 858805226. https://books.google.com/books?id=-Us1kgEACAAJ. 
  2. 2.0 2.1 "Toxicodynamic insights of 2C and NBOMe drugs - Is there abuse potential?". Toxicology Reports 14. June 2025. doi:10.1016/j.toxrep.2025.101890. PMID 39867514. Bibcode2025ToxR...1401890G. "Drugs containing a 4-benzylthio substituent (2C-T-27, 2C-T-31, and 2C-T-33) presented the highest 5-HT2A affinity but the lowest 5-HT2A activation potency, suggesting that phenethylamines with bulky lipophilic substituents might have 5-HT2 antagonistic effects. [...]". 
  3. 3.0 3.1 3.2 "Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur–Aktivitätsbeziehungen. Mitteilung 2: 4-Thio-substituierte [2-(2,5-Dimethoxyphenyl)ethyl]amine (=2,5-Dimethoxybenzolethanamine)". Helvetica Chimica Acta 86 (7): 2610–2619. 2003. doi:10.1002/hlca.200390210. ISSN 0018-019X. 
  4. 4.0 4.1 4.2 4.3 4.4 "Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)". Neuropharmacology 134 (Pt A): 141–148. May 2018. doi:10.1016/j.neuropharm.2017.07.012. PMID 28720478.